Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

HR+/HER2− breast cancer constitutes approximately 65–75% of all breast cancer cases worldwide. Although CDK4/6 inhibitors have substantially extended progression-free survival (PFS), up to 60% of patients derive no clinical benefit…

Continue ReadingTriple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

Five-treatment radiation provides excellent long-term prostate cancer control

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in the first randomized trial to directly compare the treatments…

Continue ReadingFive-treatment radiation provides excellent long-term prostate cancer control

Mediterranean rockrose extract shows strong potential against skin fungi

A polyphenol-rich extract from Cistus salviifolius, a Mediterranean rockrose species traditionally used to treat skin conditions, has shown fungicidal activity against several dermatophytes, the fungi responsible for superficial infections of…

Continue ReadingMediterranean rockrose extract shows strong potential against skin fungi